Antimycobacterial drugs

Part 3 book "Basic and clinical pharmacology" includes contents: Beta lactam and other cell wall and membrane active antibiotics; tetracyclines, macrolides, clindamycin, chloramphenicol, streptogramins and oxazolidinones; aminoglycosides and spectinomycin; sulfonamides, trimethoprim, & quinolones; antimycobacterial drugs; antifungal agents; antiviral agents; miscellaneous antimicrobial agents disinfectants, antiseptics and sterilants,... and other contents.

686p dianmotminh01 17-05-2024 4 3   Download

Part 2 book "Basic and clinical pharmacology" includes contents: Drugs used to treat diseases of the blood, inflammation, & gout; endocrine drugs, chemotherapeutic drugs; toxicology; special topics.

660p oursky01 17-07-2023 5 2   Download

A series of 3-mercapto-1,2,4-triazole–pyrrole hybrids was designed as antimycobacterial agents by employing 5- (4-(1H -pyrrol-1-yl)phenyl)-4H -1,2,4-triazole-3-thiol as the scaffold onto which several types of moieties were introduced in the triazole ring at N-4 and N-2 and as substituents of the mercapto function. The aforementioned moieties are an allyl or a phenyl moiety at N-4; an aminomethyl group at N-2; or methyl, substituted benzyl, ethoxycarbonylmethyl, or substituted phenacyl at sulfur.

16p tudichquannguyet 29-11-2021 8 1   Download

part 2 book “basic & clinical pharmacology” has contents: agents used in dyslipidemia, drugs used in disorders of coagulation, hypothalamic & pituitary hormones, thyroid & antithyroid drugs, adrenocorticosteroids & adrenocortical antagonists, cancer chemotherapy, antimycobacterial drugs,… and other contents.

660p tieu_vu13 06-08-2018 36 1   Download

Phosphorylation of the mycobacterial transcriptional activator, EmbR, is essential for transcriptional regulation of theembCABoperon encoding cell wall arabinosyltransferases. This signaling pathway eventually affects the resistance to ethambutol (a frontline antimycobacterial drug) and the cell wall Lipoarabinomannan⁄Lipomannan ratio (an important determinant for averting the host immune response).

11p dell39 27-03-2013 36 2   Download

The physician is greatly challenged to provide optimal therapy for mycobacterial illnesses because of the increase in both drug-susceptible and multidrug-resistant tuberculosis; the increasing number of pathogenic nontuberculous mycobacteria (NTM); drug-related toxicities and drug-drug interactions (especially in patients who have AIDS, with their complex antiretroviral drug regimens); and the plethora of new antibiotics with antimycobacterial potential.

19p crazy_sms 08-05-2012 63 3   Download